ITI Pharma and Healthcare Fund - Direct Plan - Growth vs Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 ITI Pharma and Healthcare Fund - Direct Plan - Growth |  Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment | |
|---|---|---|
| NAV | ₹19.4628 | ₹25.83 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +13.88% | +11.92% |
| 3 year (p.a.) | +19.03% | +15.14% |
| 5 year (p.a.) | +14.59% | +8.05% |
| Expense ratio | 0.68% | 0.84% |
| Fund size | ₹276.23 Cr | ₹950.31 Cr |
| Risk | Very high | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.